rs138419275
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_002471.4(MYH6):c.2464G>A(p.Ala822Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,614,196 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002471.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH6 | NM_002471.4 | c.2464G>A | p.Ala822Thr | missense_variant | Exon 21 of 39 | ENST00000405093.9 | NP_002462.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251338Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135856
GnomAD4 exome AF: 0.000150 AC: 220AN: 1461882Hom.: 1 Cov.: 33 AF XY: 0.000158 AC XY: 115AN XY: 727240
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74484
ClinVar
Submissions by phenotype
not specified Benign:2
- -
Ala822Thr in exon 21 of MYH6: This variant is not expected to have clinical sign ificance because it has been identified in 1.7% (3/178) of Japanese chromosomes from a broad population by the 1000 Genomes Project (dbSNP rs138419275). Ala822 Thr in exon 21 of MYH6 (rs138419275; allele frequency = 1.7%, 3/178) -
Cardiovascular phenotype Uncertain:1
The p.A822T variant (also known as c.2464G>A), located in coding exon 19 of the MYH6 gene, results from a G to A substitution at nucleotide position 2464. The alanine at codon 822 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Hypertrophic cardiomyopathy 14 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at